Associate Professor, Radiation Oncology, UCLA School of Medicine

Radiation Oncology

Percy P. Lee is an expert in the field of Radiation Oncology. He went to Harvard Medical School. Harvard Medical School is a top medical college. Harvard Medical School is ranked 1 in research and 12 in primary care medicine He received awards:"Super Doctors 2013", "CMS Meaningful Use Stage 1 Certification", "Best Doctors in America", "Americas Top Oncologists", "Full Scholarship", "Travel grant", "Resident/Fellow Research Award", "Continued Award", "Research Training Fellowship for Medical Students", "Richard J. Johns Award for Outstanding Achievement in Biomedical Engineering", "Provosts Undergraduate Award for Research and Excellence", "Undergraduate Scholarship", "Science Education Award", "Undergraduate Summer Research Fellowship", "National Merit Scholar", "Robert C. Byrd Honors Scholarship", "Selected as Best Doctor", "Selected as SuperDoctor Rising Star", "America's Top Oncologists", "ASTRO Annual Meeting Travel Grant", "Howard Hughes Medical Institute Research Training Fellowship", "Continued Award from HHMI", "RSNA Roentgen Resident Research Award", "Soma Weiss Research Day Presenter", "Summer Fellowship in Angiogenesis Research", "David William Cheever Scholarship", "Tau Beta Pi Engineering Honor Society Undergraduate Scholarship", "American Association for Cancer Research (AACR) Science Education Award", "Provost's Undergraduate Award for Research and Excellence", "Howard Hughes Medical Institute Undergraduate Summer Research Fellowship" and "AACR/ASCO Vail Clinical Trials Workshop Awardee". Doctor Percy P. Lee, MD is a published physician as well. He has 36 publications published. The latest was: The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radi... Doctor Percy P. Lee, MD is registered with Medicare.

Publications

---

• The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radi...
• The patient's perspective on stereotactic body radiation therapy (SBRT) vs. surgery for treatment of early stage non-small cell lung cancer (NSCLC).
• A Method for Assessing Ground-Truth Accuracy of the 5DCT Technique.
• 4π Noncoplanar Stereotactic Body Radiation Therapy for Head-and-Neck Cancer: Potential to Improve Tumor Control and Late Toxicity.
• Stereotactic body radiation therapy for abdominal and pelvic oligometastases: Dosimetric targets for safe and effective local control.
• Correlation of Clinical and Dosimetric Parameters With Radiographic Lung Injury Following Stereotactic Body Radiotherapy.
• Dose impact in radiographic lung injury following lung SBRT: Statistical analysis and geometric interpretation.
• A Novel Fast Helical 4D-CT Acquisition Technique to Generate Low-Noise Sorting Artifact-Free Images at User-Selected Breathing Phases.
• 4D-CT Lung registration using anatomy-based multi-level multi-resolution optical flow analysis and thin-plate splines.
• Accelerating Dynamic Magnetic Resonance Imaging (MRI) for Lung Tumor Tracking Based on Low-Rank Decomposition in the Spatial-Temporal Domain: A Feasibility Study Based...
• In reply to Sharma et al.
• A novel CT acquisition and analysis technique for breathing motion modeling.
• Assessment of Interfraction Patient Setup for Head-and-Neck Cancer Intensity Modulated Radiation Therapy Using Multiple Computed Tomography-Based Image Guidance.
• Radiation therapy for neovascular age-related macular degeneration.
• 4? Noncoplanar Stereotactic Body Radiation Therapy for Centrally Located or Larger Lung Tumors.
• Evaluation of High Ipsilateral Subventricular Zone Radiation Therapy Dose in Glioblastoma: A Pooled Analysis.
• Illustrative cases of false positive biopsies after stereotactic body radiation therapy for lung cancer based on abnormal FDG-PET-CT imaging.
• 4-Coplanar Liver SBRT: A Novel Delivery Technique.
• Radiotherapy is effective for a primary lung cancer invading the left atrium.
• Current concepts in F18 FDG PET/CT-based radiation therapy planning for lung cancer.
• Image guidance during head-and-neck cancer radiation therapy: analysis of alignment trends with in-room cone-beam computed tomography scans.
• Metabolic Tumor Volume is an Independent Prognostic Factor in Patients Treated Definitively for Non-Small-Cell Lung Cancer.
• Accelerator-Based Stereotactic Radiosurgery for Brainstem Metastases.
• Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma.
• Irradiation of the potential cancer stem cell niches in the adult brain improves progression-free survival of patients with malignant glioma.
• Is downstaging prior to liver transplantation important in hepatocellular carcinoma?
• Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.
• Feature-based rectal contour propagation from planning CT to cone beam CT.
• Neuropilin-1a is involved in trunk motor axon outgrowth in embryonic zebrafish.
• Inhibition of zebrafish epidermal growth factor receptor activity results in cardiovascular defects.
• Neuropilin-1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafish.
• Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression.
• Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins.
• Safety and efficacy of stereotactic body radiation therapy in the treatment of pulmonary metastases from high grade sarcoma.
• Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesothelioma.

Schools

---

• Harvard Medical School

Doctors Specialties

---

• Radiation Oncology

Accepted Insurances

---

• Aetna HMO
• Choice Plus POS II
• Advantage Preferred DirectAccess Plus PPO
• Blue Cross Blue Shield of California PPO
• Select Plus HMO
• Cigna HMO
• Cigna PPO
• Open Access Plus
• Commercial Insurance Company
• First Health (Coventry Health Care) PPO
• Blue & Gold HMO
• Covered California - Bronze PPO
• Employer Group HMO
• Health Net PPO
• Individual and Family PPO
• Humana
• Medicare MCR
• Kaiser PHCS Network PPO
• MultiPlan PPO
• PHCS Network PPO
• Heritage Signature
• Choice Plus POS
• Navigate HMO
• Navigate POS
• Options PPO
• PacifiCare HMO
• United Healthcare

Awards

---

• Super Doctors 2013
• CMS Meaningful Use Stage 1 Certification
• Best Doctors in America
• America’s Top Oncologists
• Full Scholarship
• Travel grant
• Resident/Fellow Research Award
• Continued Award
• Research Training Fellowship for Medical Students
• Richard J. Johns Award for Outstanding Achievement in Biomedical Engineering
• Provost’s Undergraduate Award for Research and Excellence
• Undergraduate Scholarship
• Science Education Award
• Undergraduate Summer Research Fellowship
• National Merit Scholar
• Robert C. Byrd Honors Scholarship
• Selected as Best Doctor
• Selected as SuperDoctor Rising Star
• America's Top Oncologists
• ASTRO Annual Meeting Travel Grant
• Howard Hughes Medical Institute Research Training Fellowship
• Continued Award from HHMI
• RSNA Roentgen Resident Research Award
• Soma Weiss Research Day Presenter
• Summer Fellowship in Angiogenesis Research
• David William Cheever Scholarship
• Tau Beta Pi Engineering Honor Society Undergraduate Scholarship
• American Association for Cancer Research (AACR) Science Education Award
• Provost's Undergraduate Award for Research and Excellence
• Howard Hughes Medical Institute Undergraduate Summer Research Fellowship
• AACR/ASCO Vail Clinical Trials Workshop Awardee

Education

---

• Stanford University
• Massachusetts General Hospital
• Harvard Medical School
• Johns Hopkins University

Hospital

---

• Ronald Reagan UCLA Medical Center
• Santa Monica-UCLA Medical Center and Orthopaedic Hospital

Drug Facts

---

NPI NUMBER		1447442504
NPPES Provider LastName		LEE
NPPES Provider FirstName		PERCY
NPPES Provider ZIPCode		900953075
NPPES Provider State		CA
Specialty Description		Radiation Oncology
Total Claim Count		44.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1447442504
Last Name Of The Provider	LEE
First Name Of The Provider	PERCY
View All

Similar Doctors

---

	Dr. Albert C. Mak, MD This Doctor is OpenDoctor Recommended.
	Dr. Leslie K. Ballas, MD
	Dr. Tania B. Kaprealian, MD This Doctor is OpenDoctor Recommended.
	Dr. Samuel S. Kurohara, MD
	Dr. Michael A. Tome, MD This Doctor is OpenDoctor Recommended.
	Dr. Ralph S. Wolfstein, MD This Doctor is OpenDoctor Recommended.
	Dr. Gauravjit Singh, MD This Doctor is OpenDoctor Recommended.
	Dr. Caspian Oliai, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael Girvigian, MD This Doctor is OpenDoctor Recommended.
	Dr. Caitlin L. Gomez, MD
	Dr. Eugene I. Chung, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog